Palantir has raised its revenue guidance for 2025 after a strong quarterly performance. In other news, Pfizer has taken legal action against Novo Nordisk and obesity drug start-up Metsera for the second time. Additionally, OpenAI has secured a $38 billion computing deal with Amazon, and the Trump administration is reportedly considering advocating for broader global dollar adoption, as explained by the FT’s Claire Jones.
Featured articles in this podcast:
Palantir lifts 2025 sales outlook after posting strong quarterly growth
Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid
OpenAI strikes $38bn computing deal with Amazon
US pushes for wider global dollar adoption
Today’s FT News Briefing was created by Sonja Hutson and Marc Filippino. Kelly Garry handled the mixing of the show. Additional assistance was provided by Michela Tindera, Michael Lello, and David da Silva. Topher Forhecz is the FT’s acting co-head of audio. The theme music for the show is by Metaphor Music.
Read a transcript of this episode on FT.com
Check out our accessibility guide.